Search Results - "Rimner, Andreas"

Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer by Chaft, Jamie E., Rimner, Andreas, Weder, Walter, Azzoli, Christopher G., Kris, Mark G., Cascone, Tina

“…The treatment goal for patients with early-stage lung cancer is cure. Multidisciplinary discussions of surgical resectability and medical operability determine…”
Get full text

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer by Spigel, David R, Faivre-Finn, Corinne, Gray, Jhanelle E, Vicente, David, Planchard, David, Paz-Ares, Luis, Vansteenkiste, Johan F, Garassino, Marina C, Hui, Rina, Quantin, Xavier, Rimner, Andreas, Wu, Yi-Long, Özgüroğlu, Mustafa, Lee, Ki H, Kato, Terufumi, de Wit, Maike, Kurata, Takayasu, Reck, Martin, Cho, Byoung C, Senan, Suresh, Naidoo, Jarushka, Mann, Helen, Newton, Michael, Thiyagarajah, Piruntha, Antonia, Scott J

“…The phase III PACIFIC trial compared durvalumab with placebo in patients with unresectable, stage III non-small-cell lung cancer and no disease progression…”
Get full text

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline by Kindler, Hedy L, Ismaila, Nofisat, Armato, 3rd, Samuel G, Bueno, Raphael, Hesdorffer, Mary, Jahan, Thierry, Jones, Clyde Michael, Miettinen, Markku, Pass, Harvey, Rimner, Andreas, Rusch, Valerie, Sterman, Daniel, Thomas, Anish, Hassan, Raffit

“…Purpose To provide evidence-based recommendations to practicing physicians and others on the management of malignant pleural mesothelioma. Methods ASCO…”
Get full text

Thymic carcinoma outcomes and prognosis: Results of an international analysis by Ahmad, Usman, MD, Yao, Xiaopan, PhD, Detterbeck, Frank, MD, Huang, James, MD, Antonicelli, Alberto, MD, Filosso, Pier Luigi, MD, Ruffini, Enrico, MD, Travis, William, MD, Jones, David R., MD, Zhan, Yilei, MD, Lucchi, Marco, MD, Rimner, Andreas, MD

“…Objectives The objectives of this collaborative study were to characterize patients with thymic carcinoma, their treatment patterns, and association with…”
Get full text

Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review by Käsmann, Lukas, Dietrich, Alexander, Staab-Weijnitz, Claudia A, Manapov, Farkhad, Behr, Jürgen, Rimner, Andreas, Jeremic, Branislav, Senan, Suresh, De Ruysscher, Dirk, Lauber, Kirsten, Belka, Claus

“…Lung, breast, and esophageal cancer represent three common malignancies with high incidence and mortality worldwide. The management of these tumors critically…”
Get full text

Radiomics analysis of pulmonary nodules in low‐dose CT for early detection of lung cancer by Choi, Wookjin, Oh, Jung Hun, Riyahi, Sadegh, Liu, Chia‐Ju, Jiang, Feng, Chen, Wengen, White, Charles, Rimner, Andreas, Mechalakos, James G., Deasy, Joseph O., Lu, Wei

“…Purpose To develop a radiomics prediction model to improve pulmonary nodule (PN) classification in low‐dose CT. To compare the model with the American College…”
Get full text

Outcome of primary neuroendocrine tumors of the thymus: A joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases by Filosso, Pier Luigi, MD, Yao, Xiaopan, PhD, Ahmad, Usman, MD, Zhan, Yilei, MS, Huang, James, MD, Ruffini, Enrico, MD, Travis, William, MD, Lucchi, Marco, MD, Rimner, Andreas, MD, Antonicelli, Alberto, MD, Guerrera, Francesco, MD, Detterbeck, Frank, MD

“…Objective Primary neuroendocrine tumors of the thymus (TNET) are exceedingly rare. We studied a large series of TNET identified through the International…”
Get full text

Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline by Bezjak, Andrea, Temin, Sarah, Franklin, Gregg, Giaccone, Giuseppe, Govindan, Ramaswamy, Johnson, Melissa L, Rimner, Andreas, Schneider, Bryan J, Strawn, John, Azzoli, Christopher G

“…The American Society for Radiation Oncology (ASTRO) produced an evidence-based guideline on external-beam radiotherapy for patients with locally advanced…”
Get full text

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement by Guckenberger, Matthias, Belka, Claus, Bezjak, Andrea, Bradley, Jeffrey, Daly, Megan E., DeRuysscher, Dirk, Dziadziuszko, Rafal, Faivre-Finn, Corinne, Flentje, Michael, Gore, Elizabeth, Higgins, Kristin A., Iyengar, Puneeth, Kavanagh, Brian D, Kumar, Sameera, Le Pechoux, Cecile, Lievens, Yolande, Lindberg, Karin, McDonald, Fiona, Ramella, Sara, Rengan, Ramesh, Ricardi, Umberto, Rimner, Andreas, Rodrigues, George B., Schild, Steven E., Senan, Suresh, Simone II, Charles B., Slotman, Ben J., Stuschke, Martin, Videtic, Greg, Widder, Joachim, Yom, Sue S., Palma, David

“…•Recommendations for risk-mitigation pandemic scenario:•Do not to compromise the prognosis of lung cancer patients by departing from guideline-recommended…”
Get full text

Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement by Guckenberger, Matthias, Belka, Claus, Bezjak, Andrea, Bradley, Jeffrey, Daly, Megan E., DeRuysscher, Dirk, Dziadziuszko, Rafal, Faivre-Finn, Corinne, Flentje, Michael, Gore, Elizabeth, Higgins, Kristin A., Iyengar, Puneeth, Kavanagh, Brian D., Kumar, Sameera, Le Pechoux, Cecile, Lievens, Yolande, Lindberg, Karin, McDonald, Fiona, Ramella, Sara, Rengan, Ramesh, Ricardi, Umberto, Rimner, Andreas, Rodrigues, George B., Schild, Steven E., Senan, Suresh, Simone II, Charles B., Slotman, Ben J., Stuschke, Martin, Videtic, Greg, Widder, Joachim, Yom, Sue S., Palma, David

“…The COVID-19 pandemic has caused radiotherapy resource pressures and led to increased risks for lung cancer patients and healthcare staff. An international…”
Get full text

Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma Is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy by Leeman, Jonathan E., MD, Rimner, Andreas, MD, Montecalvo, Joseph, MD, Hsu, Meier, MS, Zhang, Zhigang, PhD, von Reibnitz, Donata, BA, Panchoo, Kelly, BA, Yorke, Ellen, PhD, Adusumilli, Prasad S., MD, Travis, William, MD, Wu, Abraham J., MD

“…Purpose Stereotactic body radiation therapy (SBRT) has emerged as an effective treatment for early-stage lung cancer. The histologic subtype of surgically…”
Get full text

Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline by Videtic, Gregory M.M., Donington, Jessica, Giuliani, Meredith, Heinzerling, John, Karas, Tomer Z., Kelsey, Chris R., Lally, Brian E., Latzka, Karen, Lo, Simon S., Moghanaki, Drew, Movsas, Benjamin, Rimner, Andreas, Roach, Michael, Rodrigues, George, Shirvani, Shervin M., Simone, Charles B., Timmerman, Robert, Daly, Megan E.

“…This guideline presents evidence-based recommendations for stereotactic body radiation therapy (SBRT) in challenging clinical scenarios in early-stage…”
Get full text

Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies by Zhao, Jing, MD, PhD, Yorke, Ellen D., PhD, Li, Ling, MD, PhD, Kavanagh, Brian D., MD, Li, X. Allen, PhD, Das, Shiva, PhD, Miften, Moyed, PhD, Rimner, Andreas, MD, Campbell, Jeffrey, PhD, Xue, Jinyu, PhD, Jackson, Andrew, PhD, Grimm, Jimm, PhD, Milano, Michael T., MD, PhD, (Spring) Kong, Feng-Ming, MD, PhD

“…Purpose To study the risk factors for radiation-induced lung toxicity (RILT) after stereotactic body radiation therapy (SBRT) of the thorax. Methods and…”
Get full text

The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors by Ruffini, Enrico, Fang, Wentao, Guerrera, Francesco, Huang, James, Okumura, Meinoshin, Kim, Dong Kwan, Girard, Nicolas, Billè, Andrea, Boubia, Souheil, Cangir, Ayten Kayi, Detterbeck, Frank, Falkson, Conrad, Filosso, Pier Luigi, Giaccone, Giuseppe, Kondo, Kazuya, Infante, Maurizio, Lucchi, Marco, Marino, Mirella, Marom, Edith M, Nicholson, Andrew G, Rimner, Andreas, Rami-Porta, Ramon, Asamura, Hisao

“…The International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee-Thymic Domain conducted a web-based cross-sectional survey…”
Get more information

Pleural Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma by Rosenzweig, Kenneth E., M.D, Zauderer, Marjorie G., M.D, Laser, Benjamin, M.D, Krug, Lee M., M.D, Yorke, Ellen, Ph.D, Sima, Camelia S., M.D, Rimner, Andreas, M.D, Flores, Raja, M.D, Rusch, Valerie, M.D

“…Purpose In patients with malignant pleural mesothelioma who are unable to undergo pneumonectomy, it is difficult to deliver tumoricidal radiation doses to the…”
Get full text

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial by Basch, Ethan, Pugh, Stephanie L., Dueck, Amylou C., Mitchell, Sandra A., Berk, Lawrence, Fogh, Shannon, Rogak, Lauren J., Gatewood, Marcha, Reeve, Bryce B., Mendoza, Tito R., O'Mara, Ann M., Denicoff, Andrea M., Minasian, Lori M., Bennett, Antonia V., Setser, Ann, Schrag, Deborah, Roof, Kevin, Moore, Joan K., Gergel, Thomas, Stephans, Kevin, Rimner, Andreas, DeNittis, Albert, Bruner, Deborah Watkins

“…To assess the feasibility of measuring symptomatic adverse events (AEs) in a multicenter clinical trial using the National Cancer Institute's Patient-Reported…”
Get full text

A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma by Zauderer, Marjorie G, Tsao, Anne S, Dao, Tao, Panageas, Katherine, Lai, W Victoria, Rimner, Andreas, Rusch, Valerie W, Adusumilli, Prasad S, Ginsberg, Michelle S, Gomez, Daniel, Rice, David, Mehran, Reza, Scheinberg, David A, Krug, Lee M

“…Determine the 1-year progression-free survival (PFS) rate among patients with malignant pleural mesothelioma (MPM) receiving the WT1 peptide vaccine…”
Get full text

Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors by Arbour, Kathryn C, Naidoo, Jarushka, Steele, Keith E, Ni, Ai, Moreira, Andre L, Rekhtman, Natasha, Robbins, Paul B, Karakunnel, Joyson, Rimner, Andreas, Huang, James, Riely, Gregory J, Hellmann, Matthew D

“…The thymus is a critical organ for the development of the adaptive immune system and thymic epithelial tumors (TETs; thymomas and thymic carcinomas) are often…”
Get full text

A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients by Oberije, Cary, PhD, De Ruysscher, Dirk, MD, PhD, Houben, Ruud, MSc, van de Heuvel, Michel, MD, PhD, Uyterlinde, Wilma, MSc, PhD, Deasy, Joseph O., PhD, Belderbos, Jose, MD, PhD, Dingemans, Anne-Marie C., MD, PhD, Rimner, Andreas, MD, PhD, Din, Shaun, MD, Lambin, Philippe, MD, PhD

“…Purpose Although patients with stage III non-small cell lung cancer (NSCLC) are homogeneous according to the TNM staging system, they form a heterogeneous…”
Get full text

Breast cancer methylomes establish an epigenomic foundation for metastasis by Fang, Fang, Turcan, Sevin, Rimner, Andreas, Kaufman, Andrew, Giri, Dilip, Morris, Luc G T, Shen, Ronglai, Seshan, Venkatraman, Mo, Qianxing, Heguy, Adriana, Baylin, Stephen B, Ahuja, Nita, Viale, Agnes, Massague, Joan, Norton, Larry, Vahdat, Linda T, Moynahan, Mary Ellen, Chan, Timothy A

“…Cancer-specific alterations in DNA methylation are hallmarks of human malignancies; however, the nature of the breast cancer epigenome and its effects on…”
Get more information